Shattuck Labs (STTK) Amortizatization of Intangibles (2021 - 2026)
Shattuck Labs (STTK) reported Amortizatization of Intangibles of $48000.0 for Q1 2026, up 2300.0% year-over-year from $2000.0 in Q1 2025, and down 39.24% quarter-over-quarter from $79000.0 in Q4 2025.
Shattuck Labs (STTK) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 6 years of Amortizatization of Intangibles data on file, last reported at $48000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $48000.0, up 2300.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $499000.0 (down 75.68% YoY), and the FY2025 annual result was $453000.0, down 78.94% from the prior year.
- Amortizatization of Intangibles declined to $48000.0 in Q1 2026 per STTK's latest filing, from $79000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.8 million in Q4 2024 and troughed at -$981000.0 in Q1 2022.
- A 5-year average of $261000.0 and a median of $101000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles jumped 56200.0% in 2022, then sank 103.39% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $82000.0 in 2022, then surged by 1382.93% to $1.2 million in 2023, then jumped by 50.99% to $1.8 million in 2024, then plunged by 95.7% to $79000.0 in 2025, then sank by 39.24% to $48000.0 in 2026.
- Business Quant data shows STTK's Amortizatization of Intangibles at $48000.0 in Q1 2026, $79000.0 in Q4 2025, and $133000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 48,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48,000.00 |
| Mar 31, 2026 | 48,000.00 |
| Dec 31, 2025 | 79,000.00 |
| Dec 31, 2025 | 79,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 1.84 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 109,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |